Clinical Trials Directory

Trials / Unknown

UnknownNCT04937712

Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction

Molecular Characterization and Cellular Infection Capacity of Urinary Viral Particles Isolated From SARS-CoV-2 and Association With Proximal Tubular Dysfunction, in Hospitalized Patients With COVID-19

Status
Unknown
Phase
Study type
Observational
Enrollment
34 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The primary goal is to detect Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) urine viral particles in patients in intensive care units, hospitalized for coronavirus Coronavirus Disease-19 (COVID-19) infection, and correlate the presence of the virus in the urine with proximal tubular dysfunction (defined by the association of at least 2 abnormalities: tubular proteinuria, renal phosphate leak, uricosuria, normoglycemic glycosuria, amino aciduria)

Conditions

Interventions

TypeNameDescription
OTHERRT-PCR SARS-COV2 in urineproteinuria/renal phosphate leak/uricosuria/glycosuria/ aminoaciduria)

Timeline

Start date
2021-08-19
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2021-06-24
Last updated
2021-08-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04937712. Inclusion in this directory is not an endorsement.